[Therapy of migraine with special reference to sumatriptan].
A migraine attack results from an inflammatory process of intracranial blood vessels with secondly vasodilation. Sumatriptan activates vascular 5-HT1-receptors to constrict the affected vessels (12, 14) and clinical studies have shown, that it is highly effective in the treatment of migraine and cluster headache. Results from controlled, double-blind studies are discussed, comparing sumatriptan with placebo or standard treatment. Over all it produced faster and greater relief of migraine or cluster headache and was well-tolerated. Advising patients of the risk of side-effects is necessary; it is a safe treatment. Sumatriptan 100 mg tablets or 6 mg in pre-filled syringes for use with autoinjector are available, intranasal administration still needs testing.